More Vitasora Health Limited news
Vitasora Health LimitedASX: VHL

CE Mark, manufacturer & clinical study agreement

Dec 9, 2019 at 11:13 PM EST · Issued by Vitasora Health Limited

Filed with ASX · Dec 9, 2019 at 11:13 PM EST · 3 pages · English

On 6ix: 6ix.com/news/ce-mark-manufacturer-and-clinical-study-agreement

Vitasora Health Limited on 6ix

Story so far

  • European CE Mark Approval ReceivedApr 12, 2017

Earlier from Vitasora Health

  • Chairmans Address to ShareholdersNov 25, 2019
  • Director and CEO AppointmentNov 24, 2019
  • Change of ChairmanNov 14, 2019
  • Update regarding departure of CEOOct 29, 2019
  • CEO leavingOct 9, 2019

Later from Vitasora Health

  • SaaS model & First 500 devicesDec 12, 2019
  • Cancellation of shares and optionsDec 19, 2019
  • FDA submission to be lodgedJan 29, 2020
  • FDA updateJan 30, 2020
  • First batch of wheezos deliveredMar 5, 2020
All Vitasora Health news releases↗

Follow Vitasora Health into a list and get an email when it puts out news.

Follow Vitasora Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer